MedWatch

CEO: international outlook is needed to secure capital

Kissing a whole bunch of frogs in the hope of finding a prince might not be the way to go, says the CEO of Medicon Valley Alliance, about the roles of the Danish state and venture capital market in investing in new biotech companies. An international outlook can help bridge the gap over “the valley of death”.

Foto: Medicon Valley Alliance/PR - Stig Jørgensen

Companies that have a difficult time attracting capital are bound to complain about a lack of capital in general. But it does not mean that the perceived lack of capital is real, says Stig Jørgensen, CEO of the Danish biotech cluster-organization Medicon Valley Alliance.

In fact, the Danish venture market and the Danish state contribute more than enough capital to early biotech companies, he believes, which is in stark contrast to recent announcements from the CEO of the Danish state investment fund, Vækstfonden.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier